Clinical Trials Directory

Trials / Completed

CompletedNCT05933785

the Value of Transanal Endoscopic ISR

The Value of Transanal Endoscopic Intersphincteric Resection (taE-ISR) in Extreme Anal Preservation in Ultra-low Rectal Cancer

Status
Completed
Phase
Study type
Observational
Enrollment
260 (actual)
Sponsor
Shanghai Minimally Invasive Surgery Center · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The Intersphincteric resection (ISR) technique is an alternative for anal preservation in ultra-low rectal cancer. The transanal total mesorectal excision (TaTME) technique might compensate for the deficiencies of ISR in terms of tumor spillage and poor surgical field exposure. Thus, the investigators perform ISR through a transanal endoscopic approach (taE-ISR), seeking to evaluate the value of this innovative technique in anal preservation in ultra-low rectal cancer.

Conditions

Interventions

TypeNameDescription
PROCEDUREtransanal endoscopic ISRperform ISR using laparoscopy through transanal port

Timeline

Start date
2018-01-02
Primary completion
2021-06-30
Completion
2023-05-30
First posted
2023-07-06
Last updated
2024-03-07

Locations

2 sites across 1 country: China

Source: ClinicalTrials.gov record NCT05933785. Inclusion in this directory is not an endorsement.

the Value of Transanal Endoscopic ISR (NCT05933785) · Clinical Trials Directory